Articles tagged with Cancer Patients
A study found that Japanese patients with esophageal cancer who tested positive for DNA from Fusobacterium nucleatum had shorter cancer-specific survival compared to those without the bacterium. The presence of F. nucleatum was associated with poorer outcomes and may serve as a biomarker for prognosis.
Researchers from Colorado State University discovered that a cancer cell's shape may offer similar clues to predict how dangerous it is and guide treatment strategies. By analyzing cell shape using Zernike moments, the team was able to identify patterns that distinguish invasive osteosarcoma cell lines.
A study at the University of York found that a standard hormone supplement may increase prostate cancer cell resistance to treatment. The research suggests that proteins called SMARCs in stem cells help keep cancer alive during radiotherapy.
A recent scandal in Brazil highlights the dangers of unproven compounds being sold to cancer patients. The authors argue that skipping clinical research phases puts patients at risk of false hopes and dangerous treatments. They emphasize the need for evidence-based medicine and the importance of testing novel drug candidates.
A large prospective cohort study found associations between high BMI, waist circumference, and type 2 diabetes with increased risk for liver cancer. The study, published in Cancer Research, adds substantial support to the link between obesity-related cancers, including liver cancer.
A minimally-invasive procedure to fix an aortic aneurysm, called endovascular aneurysm repair (EVAR), may be associated with a higher risk of long-term complications, including mortality, compared to open surgery. Regular scans can help prevent these complications.
A successful trial shows that taking oral tablet Sunitinib for one year reduces the likelihood of kidney cancer returning for patients following removal of the kidney. The treatment improves disease-free survival and reduces the risk of relapse by 40-50% compared to placebo.
Patients diagnosed with cancer at emergency presentation have poorer survival rates compared to those diagnosed electively. The review highlights inequalities in socioeconomic groups and ethnicity, emphasizing the need for new screening methods and improved participation in existing screening programs to reduce emergency presentations.
A study published in the British Journal of Cancer predicts that more than 352,000 people will be diagnosed with cancer each year in the UK by 2035, a rise of 150,000 cases annually. The projected increase is largely attributed to an ageing and growing population, as well as lifestyle factors such as obesity and smoking.
A team of international scientists has outlined 14 recommendations to improve the adoption of new cancer scans in clinics. The guidelines aim to address challenges such as variability in methodologies and lack of reproducibility across laboratories.
A pooled analysis of 16 prospective multicenter trials found financial difficulties associated with a 35% greater risk of worse global quality-of-life response and a 20% increase in risk of death. Financial burden was present in 26% of patients at baseline, and worsening financial problems during treatment increased mortality risk.
A new treatment harnesses the immune system to shrink tumors in bladder cancer patients that cannot take the most effective chemotherapy. In a clinical trial, injections of pembrolizumab reduced tumor size by at least one third in 24% of patients, with six% experiencing complete responses.
Researchers discovered a novel mechanism in a combination drug therapy that disrupts cancer cells' ability to survive DNA damage. The therapy combines DNA methyltransferase inhibitors with poly-ADP-ribose polymerase inhibitors, causing massive DNA damage that leads to cancer cell death.
A new immunotherapy drug nivolumab has been shown to significantly increase survival rates and reduce adverse side effects in patients with recurrent head and neck cancer. The trial found that patients on nivolumab survived an average of 7.5 months, compared to 5.1 months for those receiving standard therapy.
A genetic signature related to metabolism has been identified as a predictor of poor patient prognosis in cancer. The discovery could lead to the development of targeted treatments and personalized therapy approaches. Further validation is needed to confirm the link between mitochondrial function and cancer survival.
A new study finds that breast cancer chemotherapy regimens with similar efficacy have significantly varying costs, affecting patients' financial burden. The study highlights the need for accessible information to inform treatment decisions and promote well-informed shared decisions regarding treatment options.
A study in the UK found that the rise in oropharyngeal squamous cell carcinoma incidence was not solely driven by human papillomavirus (HPV) positivity. The proportion of HPV-positive and -negative cases remained static, suggesting multiple factors contribute to OPSCC, including HPV infection, smoking, and alcohol consumption.
A phase I study of BAY 1163877 identified patients who will respond to the pan-FGFR inhibitor based on tumor mRNA expression, with notable activity seen in bladder cancer and adenoid cystic carcinoma. The drug was well-tolerated, revealing a toxicity profile better than other FGFR inhibitors under development.
A nationwide study in France found that the true burden of head and neck cancer is significantly higher than previously estimated. The EPICORL study revealed a five-year survival rate of 34% and a high risk of secondary primary cancers, with distant metastases at diagnosis associated with a six-fold increase in mortality.
Two phase II trials, KEYNOTE-052 and CheckMate 275, demonstrate the efficacy of PD-1 blockade with pembrolizumab and nivolumab in treating metastatic bladder cancer. The trials show a median survival benefit for patients with high PD-L1 expression.
A study by University of Minnesota researchers found that elevated levels of APOBEC3B in breast cancer cells lead to reduced response to tamoxifen therapy. Depletion of the protein accelerates development of resistance, while increased production speeds it up.
A new survey tool, COST, measures a patient's risk for financial stress and ability to tolerate it. The study identified employment status, household income, and psychological distress as key factors contributing to financial toxicity.
Studies suggest that population commitment, physician implication, and reassurance in screening can improve participation rates. A patient-centred approach in Australia improved screening participation by offering a combined cancer screening service. Additionally, nurse-led clinics can provide effective early diagnosis and prevention o...
A pooled analysis of NRG Oncology studies RTOG 0129 and 0522 found that IMRT significantly reduced xerostomia and feeding tube dependency in head and neck cancer patients, especially those with oropharyngeal cancer. However, IMRT was associated with increased acute mucositis and dysphagia.
Researchers found that a particular strain of HPV resulted in better overall survival for patients with oropharyngeal cancer. Patients infected with other strains had similar survival rates as those without HPV.
Researchers at Boston University School of Medicine have discovered a new role of the protein c-Cbl in degrading ?-catenin, a vital protein involved in cancer initiation. This finding could lead to new strategies to suppress Colorectal Cancer growth and improve patient survival.
A study published in JAMA Oncology found that training oncologists and their patients to have high-quality discussions improves communication and leads to more clinically meaningful conversations. Despite the focused efforts, shared understanding about prognosis was lacking among patients.
Researchers at Cancer Research UK Cambridge Institute developed an endoscope using near-infrared light to spot early warning signs of oesophageal cancer. The new technique could be used to monitor people with Barrett's oesophagus and prevent some cases of oesophageal cancer.
A randomized clinical trial found that early palliative care significantly increases a patient's ability to cope with their diagnosis and overall quality of life. Patients who received early palliative care were more likely to use adaptive coping strategies and report higher quality of life compared to those receiving standard care alone.
Researchers identified a unique oscillating pattern of a key cancer gene that may contribute to disease progression and treatment resistance. The study found that simultaneous treatment with chemotherapy and targeted drugs can suppress tumor cell growth in both ER+/HER2- and HER2+ subpopulations.
A new survey shows that nearly one-quarter to one-third of family caregivers experience high levels of depression and anxiety symptoms, with self-care behaviors declining as caregiving time increases. Family caregivers can spend over eight hours per day providing care, which affects their mental health if neglected.
A recent study found that many major cancer centers struggle with accessing palliative and supportive care services for patients. Only 37% of callers were told all seven supportive care services were offered, with some staff unsure about availability or unfamiliar with the term.
A recent study analyzing over 1,200 cancer caregivers in the US found that they report a significantly higher burden and spend more hours per week providing care compared to non-cancer caregivers. This highlights the need for better support systems for these individuals.
Researchers have identified three distinct subtypes of esophageal cancer based on genetic signatures, paving the way for tailored treatments. The study suggests patients with specific weaknesses in their DNA repair pathways or immune systems may benefit from targeted therapies, including PARP inhibitors and immunotherapy drugs.
A study suggests that methylnaltrexone can improve the survival of advanced cancer patients with constipation, indicating a potential target for cancer therapy. The drug works by blocking opioid receptors in the gut, reversing constipation without affecting pain relief.
Researchers have discovered a potential new biomarker that can predict cancer patient prognosis and response to treatment. The biomarker is based on the degree of gene overexpression in genes regulating genome integrity.
A large study published in The BMJ found that patients with cancer have a high risk of unintentional and intentional injuries during the diagnostic process. Injuries range from medical complications to accidents and self-harm, affecting specific types of cancer and patient groups differently.
A new study found that cancer screening guidelines for organ transplant recipients are inconsistent, varying in recommendations for skin and other types of cancer. Researchers highlight the need for more studies to inform guidelines involving transplant patients, oncologists, and cancer specialists.
Researchers have identified AMPK as the central enzyme in cancer cachexia, a condition that results in weight loss due to metabolic complications. A peptide was developed to selectively reactivate AMPK, which has been shown to prevent increased fat breakdown and promote 'healthy' adipose tissue.
A nationwide study in England has collected data on 30-day mortality for patients with breast and lung cancer treated with chemotherapy, identifying factors such as age, general well-being, and NHS trusts with higher-than-expected rates of mortality. The study aims to improve patient care and inform clinical decision-making.
Researchers at Houston Methodist developed an AI software that reliably interprets mammograms to predict breast cancer risk. The software achieves 99% accuracy in 30 times human speed, reducing unnecessary biopsies and saving physician hours.
The European Society of Cardiology has launched a position paper to tackle the cardiac toxicity of anticancer therapies. The document reviews nine categories of cardiovascular complications and provides recommendations for detection, prevention, and treatment.
A new study reveals how a cell surface molecule controls T-cell entry into the thymus, offering hope for immunotherapeutic targeting in cancer patients. The research found that stimulating Lymphotoxin beta receptor can enhance initial thymus recovery and boost transplant-derived T-cells.
Researchers at Arizona State University developed a new method to predict which BE patients are at risk of developing cancer. The study highlights the power of studying genetic diversity as a reliable predictor of cancer development and spread.
A new study reveals that socioeconomic differences between white and ethnic minority patients are the main factor affecting their chances of survival. Patients with higher income, insurance status, and marital status tend to have better outcomes.
A new study by Queen Mary University of London found that certain Barrett's Oesophagus cells can be identified as 'born to be benign' or 'bad', allowing for early detection and prevention of oesophageal cancer. The test uses genetic analysis of individual cells, predicting future risk regardless of time since abnormal cell appearance.
A study found that parents are more likely to support laws requiring HPV vaccination for school entry if their state offers opt-out provisions. However, the study's lead author warned that such opt-out provisions may weaken the vaccine requirements' effectiveness.
Patients who initially screened negative for lung cancer but developed the disease one to two years later had more aggressive disease, according to a new study by researchers at Moffitt Cancer Center. The study highlights the importance of continued lung cancer screening in high-risk patients.
A new study suggests that genomic sequencing research may be missing key mutations in different racial and ethnic groups due to a lack of tumor samples from minorities. This could lead to unequal treatment opportunities and worsen disparities in cancer care.
A systematic review found that music interventions significantly reduce cancer patients' anxiety, pain, and fatigue, while improving their quality of life. Music therapy led to a moderate increase in quality of life, while music medicine had less impact.
A new study assesses the effectiveness of self-guided online genetic education in reducing anxiety and stress among cancer patients undergoing tumor gene testing. Researchers hope to improve patients' experience with precision medicine by increasing knowledge about test limitations and benefits.
Researchers at Stanford Medicine developed a machine-learning approach that accurately differentiates between two types of lung cancers and predicts patient survival times better than human pathologists. The method assesses critical disease-related features, including cell size, shape, and texture, to improve patient outcomes.
The new guideline establishes a two millimeter margin as the standard for adequate margins in DCIS treated with whole breast radiation therapy, potentially reducing re-excision rates and improving cosmetic outcomes. This recommendation is supported by evidence and aims to improve quality of care and patient outcomes.
Patients with relapsed or resistant AML experienced responses to venetoclax, a selective BCL-2 inhibitor, with complete remissions in some. The study's results support the mechanism of action of venetoclax and offer potential as a predictive biomarker for BH3 mimetics.
Researchers developed an algorithm called JAMMIT that uses advanced mathematics to identify patterns across multiple molecular data types. The algorithm can accurately predict which patients would benefit most from chemotherapy and combining it with immunotherapy, leading to improved clinical outcomes and reduced costs.
A new study published in Cancer found that uninsured and Medicaid-covered men with testicular cancer had a higher risk of death from the disease compared to insured patients. The researchers analyzed outcomes and insurance status for 10,211 men diagnosed with testicular cancer between 2007 and 2011.
Two new studies found that uninsured or Medicaid-covered cancer patients experience delayed diagnoses, less optimal treatment, and shorter survival times compared to those with other forms of insurance. The research highlights significant disparities in cancer care across different insurance statuses.
A new study has identified gene expression profiles in renal cell carcinoma patients that are less likely to respond to the immunotherapy nivolumab. The study found that tumors with higher levels of metabolism-related genes were more likely to resist treatment and did not benefit from nivolumab, which targets PD-L1 protein.
Researchers found that over half of patients with a rare form of sarcoma had genetic errors in genes known to increase cancer risk, such as p53 and BRCA1. This study provides new clues to the phenomenon of 'cancer families' and suggests that multiple genetic mutations working together may contribute to inherited cancer predisposition.
Researchers have found a way to detect ovarian cancer early using a protein test, providing new hope for patients. An enzyme called SIK2 has been identified as key in making ovarian cancer more deadly, offering a potential new treatment target.